EyePoint, Inc. Gain (Loss) on Derivative Instruments, Net, Pretax
EyePoint, Inc. (EYPT) reported Gain (Loss) on Derivative Instruments, Net, Pretax of $0 for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-10.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDerivativeInstrumentsNetPretax · last filed 2020-03-16
- EyePoint, Inc. gain (loss) on derivative instruments, net, pretax for the quarter ending 2019-03-31 was $0.00.
- EyePoint, Inc. gain (loss) on derivative instruments, net, pretax for the quarter ending 2018-12-31 was $0.00.
- EyePoint, Inc. gain (loss) on derivative instruments, net, pretax for the quarter ending 2018-09-30 was -$18.89M.
- EyePoint, Inc. gain (loss) on derivative instruments, net, pretax for the quarter ending 2018-06-30 was -$23.95M.
- EyePoint, Inc. gain (loss) on derivative instruments, net, pretax for fiscal 2018 was -$45.16M.
- EyePoint, Inc. gain (loss) on derivative instruments, net, pretax for fiscal 2018 was -$26.28M.
- EyePoint, Inc. gain (loss) on derivative instruments, net, pretax for fiscal 2017 was $0.00.
- EyePoint, Inc. gain (loss) on derivative instruments, net, pretax for fiscal 2016 was $0.00.
| Period end | Gain (Loss) on Derivative Instruments, Net, Pretax 3 month | Gain (Loss) on Derivative Instruments, Net, Pretax 3 month as first filed | Gain (Loss) on Derivative Instruments, Net, Pretax 6 month | Gain (Loss) on Derivative Instruments, Net, Pretax 9 month | Gain (Loss) on Derivative Instruments, Net, Pretax 12 month |
|---|---|---|---|---|---|
| 2019-03-31 | $0.00 10-Q · filed 2019-05-10 | $0.00 derived: sum of 2 quarters · filed 2020-03-16 | -$18.89M derived: sum of 3 quarters · filed 2020-03-16 | -$42.84M derived: sum of 4 quarters · filed 2020-03-16 | |
| 2018-12-31 | $0.00 derived: 10-K 6 month − 10-Q 3 month · filed 2020-03-16 | -$18.89M 10-K · filed 2020-03-16 | -$42.84M derived: sum of 3 quarters · filed 2020-03-16 | -$45.16M 10-K · filed 2020-03-16 | |
| 2018-09-30 | -$18.89M 10-Q · filed 2019-11-07 | -$42.84M derived: sum of 2 quarters · filed 2019-11-07 | -$45.16M 10-Q · filed 2019-11-07 | ||
| 2018-06-30 | -$23.95M 10-Q · filed 2019-08-07 | -$1.20M 10-K · filed 2018-09-18 | -$26.28M 10-Q · filed 2019-08-07 | -$26.28M 10-K · filed 2020-03-16 | |
| 2018-03-31 | -$2.33M 10-Q · filed 2019-05-10 | -$2.33M 10-Q · filed 2018-05-10 | |||
| 2017-09-30 | $0.00 10-Q · filed 2018-11-09 | $0.00 derived: sum of 2 quarters · filed 2019-03-18 | $0.00 derived: sum of 3 quarters · filed 2019-03-18 | ||
| 2017-06-30 | $0.00 derived: 10-KT 12 month − 10-Q 9 month · filed 2019-03-18 | $0.00 derived: sum of 2 quarters · filed 2019-03-18 | $0.00 10-KT · filed 2019-03-18 | ||
| 2017-03-31 | $0.00 10-Q · filed 2018-05-10 | $0.00 10-Q · filed 2018-05-10 | |||
| 2016-06-30 | $0.00 10-KT · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |